Patrys Limited (ASX:PAB)
Australia · Delayed Price · Currency is AUD 0.0450
-0.0010 (-2.17%)
Jun 19, 2026, 2:20 PM AEST
Patrys Market Cap
Patrys has a market cap or net worth of 30 million as of June 18, 2026. Its market cap has increased by 629.03% in one year.
Market Cap
30.00M
Enterprise Value
28.09M
Revenue
100.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
Market Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 30.00M, a decrease of -69.09%. That is a compound annual growth rate of -6.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 30.00M | 214.43% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 52.22M |
| Neurizon Therapeutics | 48.51M |
| Nexsen | 44.04M |
| Imugene | 39.50M |
| EZZ Life Science Holdings | 23.77M |
| Noxopharm | 23.66M |
| NeuroScientific Biopharmaceuticals | 21.95M |
| Algorae Pharmaceuticals | 21.24M |